Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026
PR Newswire•03/11/2026•06:50 ET
0
Key Highlights
- ➤Protalix (PLX) will release third-quarter 2026 financial results on November 10, 2026
- ➤Management will provide a business update covering recent corporate and regulatory developments
- ➤Conference call and webcast scheduled for 8:00 a.m. ET on November 10
Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026 PR Newswire
CARMIEL, Israel, Nov. 3, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that it will release its financial results for the quarter ended September 30, 2026 and provide a business update on November 10, 2026.
Get started
Create a free account to read the full story.